Regression of Subcutaneous B16 Melanoma Tumors After Intratumoral Delivery of an IL-15-expressing Plasmid Followed by in Vivo Electroporation

Cancer Gene Therapy - United Kingdom
doi 10.1038/sj.cgt.7700973

Related search